Potential candidates for hepatitis C drugs have been identified in coronavirus treatment



[ad_1]

Scientists at the University of Johannes Gutenberg Mainz (JGU) studied the methods of 42,000 different ingredients that are linked to the main types of coronaviruses, that is, SARS-CoV-2, in open databases using the MOGON II supercomputer.

According to Financial Express reports, the content of anti-hepatitis C drugs was found to have a strong tendency to bind to SARS-CoV-2 according to calculations from computer simulations, so they can prevent infection. It was claimed that over 30 billion individual calculations were performed during the two months.

RESULTS PUBLISHED IN THE WHO BULLETIN

Professor Thomas Efferth, whose results led to research published in the Bulletin of the World Health Organization (WHO), said that this computer simulation has been used for years for molecular clamping. To the best of their knowledge, Efferth stated that they are the first team to investigate new types of coronaviruses with this method and said: “It is great news that we have found that many approved hepatitis C drugs are promising candidates for treatment.”

Thomas Efferth added that his findings are supported by the fact that the SARS-CoV-2 and Hepatitis C viruses are the same species, that is, the single-stranded RNA virus.

Experts also stated that the natural content of Japanese honeysuckle, which is used in various diseases in Asia, may be another powerful candidate against the new type of coronavirus.

Efferth said that in the following period, his findings should be tested by laboratory experiments and clinical studies.

You can also look at these

[ad_2]